Arun S Singh

5PUBLICATIONS
77CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 05, 2026
Neoadjuvant BO-112 and Hypofractionated Radiation Therapy with or without Nivolumab in Soft-Tissue Sarcoma: Preclinical and Phase I Results.

Jie Deng, Aastha Pal, Stefano Testa

|Dec 04, 2023
Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma.

Santosh Kesari, Naveed Wagle, Jose A Carrillo

|Sep 22, 2022
Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy.

Zev A Wainberg, Arun S Singh, Gottfried E Konecny

|Oct 30, 2021
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT.

William D Tap, Arun S Singh, Stephen Patrick Anthony

|Aug 19, 2021
A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors.

Arun S Singh, J Randolph Hecht, Lee Rosen

Pageof 1

Frequent Collaborators

4 joint publications

Bartosz Chmielowski

2 joint publications

J Randolph Hecht

2 joint publications

Fritz Christian Eilber

1 joint publications

Anahis Hagopian